RekrutujeFaza III
A Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Oral Rilzabrutinib Compared With Placebo in Participants 18 Years of Age and Older With Warm Autoimmune…
Miasta: Bydgoszcz, ŁódźWiek: od 18 latSponsor: Sanofi
RekrutujeFaza III
A phase 3, multicenter, randomized, double-blind, placebo- controlled, parallel-group study with an open-label period and long-term extension to assess the efficacy and safety of…
Miasta: Bydgoszcz, Radom, ŁódźWiek: od 18 latSponsor: Sanofi-Aventis Recherche & Developpement
RekrutujeFaza III
A Study to Evaluate Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects
Miasta: Bydgoszcz, Dębica, Katowice, Rzeszów i 2 inne miastaWiek: do 17.99 latSponsor: Amag Pharmaceuticals Inc.